Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Edelweiss Recently Listed IPO Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseEdelweissHDFC
NAV₹36.4592₹23.6750
NAV date20 Nov 202620 Nov 2026
History8.7 years3.1 years
Expense ratio1.4%1.1%
Stars★★★★★★★★★★
Growth Score45.2094.50

Returns

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
1 month+5.92%+12.97%
3 months+2.40%+7.13%
6 months+20.35%+17.84%
YTD+25.20%+33.73%
1 year+23.75%+32.20%
3 years (CAGR)+17.13%+30.70%
5 years (CAGR)+11.04%—
10 years (CAGR)——
Since launch+15.95%+31.83%

Risk

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
Volatility20.9%15.8%
Downside volatility12.9%8.5%
Sharpe0.511.53
Sortino0.822.86
Calmar0.692.06
Return / risk0.821.95
Deepest fall−32.34%−14.91%
Days to recover155126
Below its high−1.63%+0.00%

Against benchmark

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
Alpha+5.69%+7.54%
Beta0.970.97
R²56.3%85.0%
Up capture114.2%108.9%
Down capture93.5%71.0%
Tracking error13.8%6.1%
Information ratio0.401.17
Treynor0.100.24

Consistency

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
Best 1-year+98.01%+67.01%
Middle 1-year+17.30%+23.25%
Worst 1-year−23.25%+1.71%
1-year periods with a loss23.7%0.0%
Middle 3-year+18.97%+30.22%
Positive months66.7%72.2%
Best day+3.68%+3.18%
Worst day−5.79%−3.61%
Worst 5% day−1.93%−1.51%
Positive days57.6%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
5-year XIRR+17.87%—
5-year value₹9,45,521—
3-year XIRR+18.35%+27.71%
1-year XIRR+35.31%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth